These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 1967919)

  • 1. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.
    Belaich S; Bruttmann G; DeGreef H; Lachapelle JM; Paul E; Pedrali P; Tennstedt D
    Ann Allergy; 1990 Feb; 64(2 Pt 2):191-4. PubMed ID: 1967919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis.
    Horak F; Bruttmann G; Pedrali P; Weeke B; Frølund L; Wolff HH; Christophers E
    Arzneimittelforschung; 1988 Jan; 38(1):124-8. PubMed ID: 2896508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis.
    Monroe EW
    Clin Ther; 1992; 14(1):17-21. PubMed ID: 1349509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loratadine (SCH29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of seasonal allergic rhinitis.
    Bruttmann G; Pedrali P
    J Int Med Res; 1987; 15(2):63-70. PubMed ID: 2884152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
    Dubertret L; Murrieta Aguttes M; Tonet J
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis.
    Del Carpio J; Kabbash L; Turenne Y; Prevost M; Hebert J; Bedard PM; Nedilski M; Gutkowski A; Schulz J
    J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):741-6. PubMed ID: 2572617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria.
    van Joost T; Blog FB; Westerhof W; Jansen FC; Starink TM; den Boer MS; Kuneman JJ; Harvey SG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():14B-17B. PubMed ID: 2569995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria.
    Boggs PB; Ellis CN; Grossman J; Washburne WF; Gupta AK; Ball R; Shulan D
    Ann Allergy; 1989 Dec; 63(6 Pt 2):616-20. PubMed ID: 2574555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients.
    Paul E; Bödeker RH
    Ann Allergy; 1989 Apr; 62(4):318-20. PubMed ID: 2565098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients].
    Paul E; Bödeker RH
    Z Hautkr; 1985; 60 Suppl 1():50-5. PubMed ID: 2859714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria.
    Monroe EW; Bernstein DI; Fox RW; Grabiec SV; Honsinger RW; Kalivas JT; Katz HI; Cuss F; Danzig MR; Garvin PR
    Arzneimittelforschung; 1992 Sep; 42(9):1119-21. PubMed ID: 1445478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of once daily loratadine versus terfenadine in the treatment of allergic rhinitis.
    Banov CH
    J Int Med Res; 1989; 17(2):150-6. PubMed ID: 2566536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action.
    Oei HD
    Ann Allergy; 1988 Dec; 61(6):436-9. PubMed ID: 2904776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind placebo controlled study of terfenadine in the treatment of chronic idiopathic urticaria.
    Salisbury J; Bor S; Blair C
    Br J Clin Pract; 1987 Aug; 41(8):859-61. PubMed ID: 2896512
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antihistaminic therapy of chronic urticaria. Results of a multicenter study with azatadine and terfenadine].
    Neumann Y
    Fortschr Med; 1984 Oct; 102(38):967-70. PubMed ID: 6209194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of chronic allergic skin diseases in a pediatric population.
    Lutsky BN; Schuller JL; Cerio R; Chieira ML; Giannetti A; Gonçalves HM; deGroot LJ; Vareltzides A; Guillot B; Lynde CW
    Arzneimittelforschung; 1993 Nov; 43(11):1196-9. PubMed ID: 8292064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acrivastine versus terfenadine in the treatment of symptomatic dermographism--a double-blind, placebo-controlled study.
    Boyle J; Marks P; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():9B-13B. PubMed ID: 2570004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset of action of loratadine and placebo and other efficacy variables in patients with seasonal allergic rhinitis.
    Bédard PM; Del Carpio J; Drouin MA; Yang W; Hébert J; Lavoie A; Prévost M; Turenne Y; PetitClerc C; Lorber R
    Clin Ther; 1992; 14(2):268-75. PubMed ID: 1351796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
    Nelson HS; Reynolds R; Mason J
    Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
    Sastre J
    Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.